Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers
Authors
Keywords
-
Journal
PLoS One
Volume 13, Issue 10, Pages e0206008
Publisher
Public Library of Science (PLoS)
Online
2018-10-19
DOI
10.1371/journal.pone.0206008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
- (2018) Wei Li et al. Cell Metabolism
- Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis
- (2017) Hector L. Franco et al. GENOME RESEARCH
- Molecular genetics and cellular events of K-Ras-driven tumorigenesis
- (2017) G G Jinesh et al. ONCOGENE
- Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis
- (2017) Goodwin G. Jinesh et al. Scientific Reports
- Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks
- (2016) Goodwin G. Jinesh et al. APOPTOSIS
- Blebbishields and mitotic cells exhibit robust macropinocytosis
- (2016) Goodwin G. Jinesh et al. BIOFACTORS
- Blebbishield emergency program: an apoptotic route to cellular transformation
- (2016) G G Jinesh et al. CELL DEATH AND DIFFERENTIATION
- RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
- (2016) Yajing Liu et al. CLINICAL CANCER RESEARCH
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Non-CpG methylation by DNMT3B facilitates REST binding and gene silencing in developing mouse hearts
- (2016) Donghong Zhang et al. NUCLEIC ACIDS RESEARCH
- Novel PKC-ζ to p47phox interaction is necessary for transformation from blebbishields
- (2016) Goodwin G. Jinesh et al. Scientific Reports
- Smac mimetic with TNF- targets Pim-1 isoforms and reactive oxygen species production to abrogate transformation from blebbishields
- (2015) G. G. Jinesh et al. BIOCHEMICAL JOURNAL
- MicroRNA-520g Confers Drug Resistance by Regulating p21 Expression in Colorectal Cancer
- (2015) Yang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Predicting response and survival in chemotherapy-treated triple-negative breast cancer
- (2014) A Prat et al. BRITISH JOURNAL OF CANCER
- MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
- (2014) Aoife Ward et al. JOURNAL OF PATHOLOGY
- The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor
- (2014) Kristen L. Karlin et al. Cell Reports
- Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives
- (2014) Goodwin G. et al. Current Stem Cell Research & Therapy
- Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries
- (2013) J. S. Jakobsen et al. GENOME RESEARCH
- Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR
- (2013) Claudia L Kleinman et al. NATURE GENETICS
- Genomic Insights into Triple-Negative and HER2-Positive Breast Cancers Using Isogenic Model Systems
- (2013) Prakriti Mudvari et al. PLoS One
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells
- (2013) J. Zuin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis
- (2012) G G Jinesh et al. CELL DEATH AND DIFFERENTIATION
- The microRNA cluster C19MC is deregulated in parathyroid tumours
- (2012) Valentina Vaira et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2
- (2012) Francesca Fornari et al. JOURNAL OF PATHOLOGY
- MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma
- (2012) Claudia Augello et al. LIVER INTERNATIONAL
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Regulatory evolution through divergence of a phosphoswitch in the transcription factor CEBPB
- (2011) Vincent J. Lynch et al. NATURE
- The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas
- (2010) Volkhard Rippe et al. PLoS One
- The Transcription Factor REST Is Lost in Aggressive Breast Cancer
- (2010) Matthew P. Wagoner et al. PLoS Genetics
- C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts
- (2009) M.-L. Bortolin-Cavaille et al. NUCLEIC ACIDS RESEARCH
- Profiling RE1/REST-mediated histone modifications in the human genome
- (2009) Deyou Zheng et al. GENOME BIOLOGY
- Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
- (2008) Mary Jo Lund et al. BREAST CANCER RESEARCH AND TREATMENT
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Critical Role for Transcription Factor C/EBP- in Regulating the Expression of Death-Associated Protein Kinase 1
- (2008) P. Gade et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started